NEW YORK -- Royalty Pharma is raising its offer to buy Elan on the condition that shareholders reject the Irish drugmaker's push to refocus its business through a string of recently announced deals.Royalty says it will pay $12.50 in cash for each ... Miami Herald, 7 hours ago
UPDATE 2-Royalty ups Elan bid and issues shareholder ultimatum - Reuters, 7 hours ago
Royalty Pharma ups offer for Elan to $12.50/shr - Reuters, 9 hours ago
See all (370) images for "elan"
Elan Corporation, plc (NYSE: ELN) (Elan) today announces a series of transactions designed to decisively transform and advance the company. Upon shareholder approval, the totality of these strategically driven decisions, in addition to the ...Street Insider, 15 hours ago UPDATE 1-Elan strikes more deals to repel Royalty bid CNBC, 16 hours ago Elan announces two acquisitions Irish Times, 17 hours ago Elan strikes more deals, agrees second share buyback Yahoo! UK and Ireland, 19 hours ago
Elan Corp, the Irish neuroscience-focused biotechnology company that is resisting a takeover bid from Royalty Pharma, has acquired two small rare disease drugmakers for $380 million. The Dublin-based company has acquired Vienna-based AOP Orphan ...Domain-B, 8 hours ago Elan fends off takeover bid, plans acquisitions MedCity News, 10 hours ago Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK), Elan Corporation, plc (ADR) (ELN): Who Benefits From This Market Moving Biotechnology Partnership? InsiderMonkey.com, 6 days ago Elan launches US$1bn pharma royalty deal TCE Today, 6 days ago
Biotechnology company Elan Corporation plc (NYSE:ELN) said on Monday that it plans to offer USD800.0m in aggregate principal amount of senior notes due 2021. This proposed offering, which is subject to market conditions, has been initiated by the ...Individual.com, 8 hours ago Elan Acquires AOP Orphan for $340 Million as It Resists Bid La Repubblica, 16 hours ago Elan Makes Two Acquisitions for $380 Million as It Resists Bid Washington Post, 17 hours ago Elan To Offer $800 Mln Of Senior Notes Due 2021; Announces Several Transactions RTTNews.com, 18 hours ago
(Financial News Network On) Elan's stock is up 2.4% to $11.95 on heavy trading volume. About 23.9 million shares have been traded today, as compared to the 30-day average volume of 6.5 million shares. Unusually high volume can signify a potential ...Individual.com, 7 hours ago Elan Shares Climbing Higher, Up 2.4% Individual.com, 8 hours ago Elan Trading Higher Today on Above-Average Volume, Consistent With Trend (ELN) Comtex SmarTrend, 7 hours ago Elan Shares Sinking Lower, Down 2.1% Individual.com, 1 week ago
6:09pm BST LONDON, May 20 (Reuters) - Elan Corporation PLC : * Elan shareholders are strongly advised to take no action in relation to the royalty pharma offer * Source textReuters UK, 8 hours ago
|Morningstar Canada, 9 hours ago|
Form 38.5 - Elan Corporation plc FORM 38.5 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS 1. KEY INFORMATION 2. DEALINGS (Note 2) ...Reuters, 15 hours ago Form 38.5 Elan Corporation Plc TrustNet, 15 hours ago ISE Only - REPLACEMENT - ELAN CORP PLC TrustNet, 17 hours ago Form 8.5 Elan Corporation Plc TrustNet, 3 days ago
More from: , Morningstar UK...and 4 other sources
|BusinessWeek, 12 hours ago Form 6-K ELAN CORP PLC For: May 15 Street Insider, 5 days ago Form 6-K ELAN CORP PLC For: May 16 Street Insider, 3 days ago|
LONDON, May 20 (IFR) - Irish drugmaker Elan will stage a return to the bond market this week with a USD800m high-yield offering that will fund share purchases, capital expenditure and acquisitions. The company, rated Ba3/B+, announced Morgan Stanley ...Reuters, 15 hours ago US high-yield issuers rush to market Yahoo! UK and Ireland, 9 hours ago
on your WebpageAdd Widget >Get your members hooked!